LatAm / What Pharma Country Managers Need to Succeed
Two Big Pharma SVPs with responsibility for the entirety of Latin America weigh in on the management challenges inherent in LatAm and what they look for when appointing country managers…
Americas
Global / Takeda Dengue Vaccine’s EU Go-Ahead Sets the Stage for More Approvals
After gaining its first global approval in Indonesia, Takeda’s dengue fever vaccine, Qdenga, recently got a green light from the European Commission (EC) to market the vaccine in Europe, laying the foundation for further approvals in dengue-endemic regions like Latin…
LatAm / Indian Investment; Bayer Looks to Mexico; Brazilian Big Pharma Manufacturing
A roundup of some of the latest from Latin American pharma, including India’s interest in the South American market, Bayer’s USD 361 million investment in Mexico, the EU’s partnership to…
LatAm / Regulatory Trends in One of the World’s Most Dynamic Pharma Markets
Collaboration, convergence, and other best practices have been at the center of discussions related to the regulatory environment in Latin America and the Caribbean, including DIA’s Latin America Regulatory Conference (LARC)…